Expect Less Concern Over Psychiatric Effects With Champix and Zyban

You'll see less concern about psychiatric events with Champix (varenicline) or Zyban (bupropion SR) for smoking cessation.

Warnings about mood changes, agitation, nightmares, and other psychiatric risks are based on case reports.

Now a large trial suggests that these meds do NOT increase those side effects in patients quitting smoking.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote